Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000435767> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2000435767 endingPage "232" @default.
- W2000435767 startingPage "226" @default.
- W2000435767 abstract "Serum thymidine kinase (STK) levels have recently been used to detect tumour regression and progression in a number of hematological malignancies. In this study, patients with myeloma were monitored longitudinally for STK and several other potentially useful tumour markers to determine which laboratory parameters are the most useful for differentiating between stable and progressive disease. STK was determined by radioenzyme assay, lymphocyte surface markers were analysed by flowcytometry, plasma cell labelling index (LI) by immunofluorescence with anti BU-1, serum B2-microglobulin (SB2M) by radioimmunoassay and M proteins by radial immunodiffusion. Detailed multiparameter longitudinal investigations of 5 patients and ongoing studies of 70 other patients suggest that STK is a more reliable marker of progressive disease than either SB2M, LI, M-protein or CD10 positive lymphocytes. A rise in STK during the emergence of progressive disease at least paralleled and usually preceded any change in the other parameters which often did not change at all. All samples from patients with progressive disease (n = 29) had a STK above the normal range (0–5U/I) whereas 76% of patients in clear stable disease had a STK within the normal range. All samples (n = 34) from patients with light chain isotype suppression (LCIS) had STK values of less than 12 U/L and 82% of samples (n = 33) from patients without LCIS had a STK above the normal range (0–5U/L). The correlation between STK and LI was r = 0.65; p < 0.001 (n = 21). The radioenzyme assay for STK is simple, reproducible and a valuable tool for monitoring patients with myeloma and when used in conjunction with other clinical and laboratory investigations, aids in the separation of patients with stable myeloma from patients whose disease is progressive." @default.
- W2000435767 created "2016-06-24" @default.
- W2000435767 creator A5072125228 @default.
- W2000435767 creator A5078508605 @default.
- W2000435767 creator A5080617550 @default.
- W2000435767 creator A5087066340 @default.
- W2000435767 date "1989-06-01" @default.
- W2000435767 modified "2023-10-18" @default.
- W2000435767 title "SERUM THYMIDINE KINASE AS A MARKER OF DISEASE ACTIVITY IN PATIENTS WITH MULTIPLE MYELOMA" @default.
- W2000435767 cites W1558799928 @default.
- W2000435767 cites W1696691642 @default.
- W2000435767 cites W1963647417 @default.
- W2000435767 cites W1973155743 @default.
- W2000435767 cites W1994358901 @default.
- W2000435767 cites W1997959134 @default.
- W2000435767 cites W2001575671 @default.
- W2000435767 cites W2006382315 @default.
- W2000435767 cites W2013470487 @default.
- W2000435767 cites W2031078693 @default.
- W2000435767 cites W2042728261 @default.
- W2000435767 cites W2055235688 @default.
- W2000435767 cites W2056448573 @default.
- W2000435767 cites W2061210304 @default.
- W2000435767 cites W2091371739 @default.
- W2000435767 cites W2094388623 @default.
- W2000435767 cites W2098355416 @default.
- W2000435767 cites W2104864926 @default.
- W2000435767 cites W2113457667 @default.
- W2000435767 cites W2206948290 @default.
- W2000435767 cites W2472662053 @default.
- W2000435767 cites W37889860 @default.
- W2000435767 doi "https://doi.org/10.1111/j.1445-5994.1989.tb00251.x" @default.
- W2000435767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2528340" @default.
- W2000435767 hasPublicationYear "1989" @default.
- W2000435767 type Work @default.
- W2000435767 sameAs 2000435767 @default.
- W2000435767 citedByCount "27" @default.
- W2000435767 countsByYear W20004357672020 @default.
- W2000435767 countsByYear W20004357672022 @default.
- W2000435767 crossrefType "journal-article" @default.
- W2000435767 hasAuthorship W2000435767A5072125228 @default.
- W2000435767 hasAuthorship W2000435767A5078508605 @default.
- W2000435767 hasAuthorship W2000435767A5080617550 @default.
- W2000435767 hasAuthorship W2000435767A5087066340 @default.
- W2000435767 hasConcept C126322002 @default.
- W2000435767 hasConcept C176685330 @default.
- W2000435767 hasConcept C203014093 @default.
- W2000435767 hasConcept C2776364478 @default.
- W2000435767 hasConcept C2777761686 @default.
- W2000435767 hasConcept C2778822529 @default.
- W2000435767 hasConcept C2779134260 @default.
- W2000435767 hasConcept C71924100 @default.
- W2000435767 hasConceptScore W2000435767C126322002 @default.
- W2000435767 hasConceptScore W2000435767C176685330 @default.
- W2000435767 hasConceptScore W2000435767C203014093 @default.
- W2000435767 hasConceptScore W2000435767C2776364478 @default.
- W2000435767 hasConceptScore W2000435767C2777761686 @default.
- W2000435767 hasConceptScore W2000435767C2778822529 @default.
- W2000435767 hasConceptScore W2000435767C2779134260 @default.
- W2000435767 hasConceptScore W2000435767C71924100 @default.
- W2000435767 hasIssue "3" @default.
- W2000435767 hasLocation W20004357671 @default.
- W2000435767 hasLocation W20004357672 @default.
- W2000435767 hasOpenAccess W2000435767 @default.
- W2000435767 hasPrimaryLocation W20004357671 @default.
- W2000435767 hasRelatedWork W1976362125 @default.
- W2000435767 hasRelatedWork W1980166143 @default.
- W2000435767 hasRelatedWork W1982640511 @default.
- W2000435767 hasRelatedWork W2027340926 @default.
- W2000435767 hasRelatedWork W2027703819 @default.
- W2000435767 hasRelatedWork W2043105234 @default.
- W2000435767 hasRelatedWork W2072014172 @default.
- W2000435767 hasRelatedWork W2153052119 @default.
- W2000435767 hasRelatedWork W2159598174 @default.
- W2000435767 hasRelatedWork W2435227317 @default.
- W2000435767 hasVolume "19" @default.
- W2000435767 isParatext "false" @default.
- W2000435767 isRetracted "false" @default.
- W2000435767 magId "2000435767" @default.
- W2000435767 workType "article" @default.